Skip to main content
. Author manuscript; available in PMC: 2016 Dec 7.
Published in final edited form as: Cancer. 2008 May 15;112(10):2112–2118. doi: 10.1002/cncr.23427

TABLE 1.

European LeukemiaNet Response Definitions and Monitoring Recommendations in Patients With Chronic Myeloid Leukemia

Cytogenetic response (% Ph-positive metaphases) Molecular response (BCR-ABL transcript level)
Definitions Complete: 0% Complete: transcript is nonquantifiable and nondetectable
Partial: 1–35%
Major: ≤35%
Minor: 36–65%
Minimal: 66–95% Major: ≤0.10 ratio for BCR-ABL: standardized control gene
None: >95%
Monitoring Check at least every 6 mo until complete response achieved and confirmed, then at least every 12 mo Check every 3 mo; mutational analysis in case of failure, suboptimal response, or transcript level increase

Ph indicates Philadelphia chromosome. Adapted from Baccarani 2006.6